Key takeaways
- Check the formulation as well as the ingredient. Olanzapine dissolving tablets need dry hands and peeled foil; aripiprazole injections go into the upper arm or buttocks and require an appointment if missed. These formats change administration, while retaining the ingredient’s adverse effects. HealthHub olanzapine, aripiprazole
- NICE specifies early weight checks. After recording weight, waist, pulse, blood pressure, glucose, lipids, prolactin and movement symptoms before treatment, its schedule includes weight weekly for 6 weeks, at 12 weeks, at 1 year and annually. ECG testing depends on the product and clinical circumstances. NICE
- Restlessness may be akathisia. NICE warns that this movement effect can resemble agitation or anxiety. HealthHub’s olanzapine guide also names neck or facial spasms and upward rolling of the eyes. Record when stiffness, sedation or slowing began and discuss them before changing treatment. NICE, HealthHub
Antipsychotic medicines differ in formulation, effects and monitoring
Antipsychotics can reduce psychotic symptoms and relapse risk, but they are not interchangeable “strong” and “weak” versions of one treatment. Oral tablets, dissolving tablets, liquids and long-acting injections solve different practical problems. Each medicine has a distinct balance of metabolic, movement, hormonal, sedating and cardiovascular effects, so selection is a shared clinical decision and monitoring is part of treatment, not an optional extra.
What can antipsychotic medicine do, and what can it not do alone?
Antipsychotics are used for symptoms such as hallucinations, delusions, severe thought disorganisation and agitation in schizophrenia and other conditions. They may also be used in bipolar disorder, severe depression or other specialist contexts. The indication matters because the expected benefit, duration and alternatives differ.
Medicine is only one part of schizophrenia care. Psychological treatment, family intervention, physical healthcare, social and occupational support and early-intervention services address needs that a tablet cannot. NICE advises that a first presentation of sustained psychotic symptoms should not be started on antipsychotic treatment in primary care without consultant-psychiatrist involvement; see its psychosis and schizophrenia recommendations.
How do oral and long-acting formulations differ?
Oral products change swallowing and daily routines; long-acting injections also need clinic and follow-up arrangements. The ingredient’s adverse effects still apply. HealthHub describes aripiprazole injection into the upper arm or buttocks, and tells patients to contact their doctor for another appointment if an injection is missed.
NICE recommendation 1.5.5.3 considers long-acting treatment after an acute episode when the person prefers it or avoiding non-adherence is a clinical priority. The next recommendation asks clinicians to discuss regular intramuscular injections, home visits and clinic location. Travel, injection-site experience and establishing tolerability belong in that plan. Once an injection has been given it cannot be removed; ask how adverse effects will be managed while it remains active.
The exact formulation name also matters. For example, standard and extended-release quetiapine have different handling instructions. A milligram-to-milligram swap between release forms or between oral and injectable products should never be inferred from a catalogue.
Why do side-effect discussions differ between medicines?
All antipsychotics can cause adverse effects, but their relative patterns differ. Olanzapine commonly raises questions about appetite, weight, glucose and lipids. Risperidone may raise prolactin and can cause movement effects. Aripiprazole can be less sedating for some people but may cause marked inner restlessness or impulse-control problems. Quetiapine can cause drowsiness, postural dizziness, appetite and metabolic effects.
HealthHub’s olanzapine guide asks about smoking changes: smoking can reduce the amount of olanzapine in the body. Its quetiapine guide flags drowsiness and dizziness on standing. The aripiprazole guide includes excessive urges to gamble, shop, eat or have sex among effects needing medical attention. These examples describe different effects, without ranking medicines or predicting an individual response.
The prescriber also needs previous benefit, heart rhythm, seizures, diabetes, blood pressure, prolactin symptoms, constipation, falls, pregnancy, alcohol or substance use and interacting medicines. Symptoms that interfere with work, walking or sleep belong in that discussion even when blood results are normal.
What does monitoring look for?
Monitoring records physical health, movement and daily functioning before and during treatment. NICE recommendation 1.3.6.1 specifies weight, waist circumference, pulse, blood pressure, glucose or HbA1c, lipids, prolactin, movement symptoms, nutrition and activity before treatment. Recommendation 1.3.6.2 adds an ECG when the product information requires it, cardiovascular risk is identified, there is a history of cardiovascular disease, or the person is being admitted as an inpatient.
For ongoing care, NICE schedules pulse, blood pressure, glucose or HbA1c and lipids at 12 weeks, 1 year and annually. Waist circumference is checked annually; weight has the earlier checks listed above. Its recommendation 1.3.6.5 keeps monitoring with the secondary-care team for at least 12 months or until the condition has stabilised, whichever is longer. Responsibility can then transfer under shared-care arrangements. Ask who will arrange each check.
| Domain | Examples to record or test | Why it matters |
|---|---|---|
| Metabolic | Weight, waist, blood pressure, glucose/HbA1c, lipids | Detects medicine-associated weight and cardiometabolic change |
| Movement | Tremor, stiffness, spasms, restlessness, slowed movement, involuntary face or limb movements | Distinguishes treatable adverse effects from anxiety, agitation or illness symptoms |
| Hormonal/sexual | Menstrual change, breast symptoms, sexual function; prolactin when relevant | Identifies clinically important prolactin effects |
| Cardiovascular | Pulse, blood pressure, fainting history and ECG when indicated | Checks postural and rhythm concerns |
| Everyday function | Alertness, sleep, swallowing, constipation, driving, work and adherence | Measures whether the formulation is sustainable |
Monitoring should become more frequent when treatment changes or results are abnormal. It should not be postponed until the annual review when rapid weight gain, new movement symptoms or significant functional impairment appears.
Which symptoms need urgent assessment?
High fever with severe stiffness, confusion, altered consciousness or unstable pulse or blood pressure can indicate neuroleptic malignant syndrome and needs emergency assessment. New severe muscle spasm affecting the neck, jaw, eyes, breathing or swallowing also needs urgent care. Seek prompt help for fainting, seizure, chest pain, severe allergic swelling, suspected overdose or new suicidal or violent crisis.
New or worsening hallucinations, suspiciousness, disorganisation, major sleep change, withdrawal from usual activity or missed treatment may be early relapse signs for some people. The useful response is the person’s agreed relapse or crisis plan, not an unsupervised extra dose or sudden medicine change.
What changes the answer?
Diagnosis, previous response, formulation preferences, physical health and other medicines shape the choice.
- Diagnosis and current phase. First-episode psychosis, maintenance treatment, bipolar mania and augmentation for depression are different decisions.
- Previous response. Benefit and adverse effects from a known medicine often matter more than a general class comparison.
- Formulation preference. Daily tablets, swallowing, privacy, travel and clinic attendance affect what is workable.
- Physical health. Diabetes, obesity, cardiovascular disease, seizures, constipation, falls and movement disorders change risk.
- Other substances and medicines. Alcohol, smoking changes, sedatives, stimulants, recreational drugs and interacting prescriptions can alter exposure or symptoms.
- Pregnancy or pregnancy planning. Risks differ by medicine and stage, and abrupt stopping can also carry substantial risk.
What should you bring to a medicine review?
Bring the exact packs or injection record, current dose schedule, missed doses, smoking or alcohol changes, every prescribed and non-prescribed product, and the dates of new sleep, appetite, movement, menstrual, sexual or alertness changes. Ask which effects the medicine is targeting, how success will be measured, which laboratory checks are due and who is responsible for each follow-up.
In Singapore, call 995 for immediate danger. National mindline 1771 and Samaritans of Singapore 1767 provide 24-hour support. The schizophrenia condition page and mental-health category can help identify catalogue terms but cannot select or stop treatment.
Do and don’t
Do:
- Keep the packs or injection record for review, including the exact release form.
- Note the dates of new movement, sleep, appetite or hormonal symptoms.
- Confirm who arranges the physical checks and follow-up appointments.
Don’t:
- Split, crush or chew quetiapine XR: HealthHub specifies swallowing this extended-release tablet whole.
- Use wet hands to handle an olanzapine orodispersible tablet; it can dissolve before it reaches the mouth.
- Delay reporting rapid weight gain, new movement symptoms or impaired daily functioning until the annual review.
Sources
- NICE: Psychosis and schizophrenia in adults - recommendations.
- HealthHub Singapore: Olanzapine.
- HealthHub Singapore: Quetiapine.
- HealthHub Singapore: Aripiprazole.
- HealthHub MindSG: Preventing self-harm and suicide - helplines.
